| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 130,361 | 114,001 | 116,524 | 133,770 | | Cost of Revenue | 85,513 | 79,362 | 78,734 | 89,334 | | | Gross Profit | 44,848 | 34,639 | 37,790 | 44,436 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 30,467 | 24,015 | 25,171 | 25,255 | | Non Recurring | (3,703) | (1,336) | 5,039 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 20,785 | 11,960 | 7,580 | 19,181 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,104 | 102 | 91 | 709 | | Earnings Before Interest And Taxes | 21,188 | 12,062 | 7,671 | 19,890 | | Interest Expense | 6,160 | 6,423 | 5,933 | 6,561 | | Income Before Tax | 15,028 | 5,639 | 1,738 | 13,329 | | Income Tax Expense | 3,686 | 1,407 | 781 | 6,574 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 11,342 | 4,232 | 957 | 6,755 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 162 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 11,342 | 4,232 | 957 | 6,917 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $11,342 | $4,232 | $957 | $6,917 |
|
0.05% Nasdaq 
Income Statement
